NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its

Joon Shin1, Goutam Chakraborty, Nagakumar Bharatham

  • 1School of Biological Sciences, Nanyang Technological University, Singapore 637551.

Insights

The structure of human Vaccinia-related kinase 1 (VRK1) was determined using NMR, revealing its C-terminal tail is crucial for catalytic activity and stability. Deleting this tail significantly reduced VRK1

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Vaccinia-related kinase 1 (VRK1) is a constitutively active mitotic kinase involved in cell cycle regulation.
  • Previous studies determined the structures of VRK2 and VRK3, but VRK1's structure remained uncharacterized.
  • VRK1 plays critical roles in nuclear condensation and transcription regulation.

Purpose of the Study:

  • To determine the nuclear magnetic resonance (NMR) solution structure of a catalytically active form of human VRK1.
  • To elucidate the role of VRK1's extended C-terminal tail in its structural stability and catalytic function.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the 3D structure of human VRK1 (residues 1-361).
  • Deletion mutant studies were performed to investigate the function of the C-terminal tail.
  • NMR titration studies with ATP or ATP analogs were conducted to analyze ligand interactions.

Main Results:

  • The NMR structure revealed that the C-terminal tail of VRK1 interacts with the catalytic site, contributing to stability and catalysis.
  • Deletion of the C-terminal tail resulted in a significant decrease in VRK1's autocatalytic activity.
  • ATP/ATP analog binding studies confirmed interactions with key kinase motifs and also involved residues from the C-terminal tail.

Conclusions:

  • The extended C-terminal tail is essential for the structural integrity and catalytic activity of human VRK1.
  • The catalytic domain of VRK1, despite the tail's involvement, follows conventional protein kinase architecture.
  • These findings highlight the unique regulatory mechanism of VRK1 involving its C-terminal tail.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...